Future Directions in Molecular Imaging Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Future Directions in Molecular Imaging. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Future Directions in Molecular Imaging Indian Medical PG Question 1: Techniques used for protein expression proteomics study include:
- A. PolyAcrylamide Gel Electrophoresis (PAGE)
- B. Gene Expression Analysis (indirectly related to proteomics)
- C. Mass Spectrometry
- D. All of the options (Correct Answer)
Future Directions in Molecular Imaging Explanation: ***All of the options***
- All listed techniques—**Polyacrylamide Gel Electrophoresis (PAGE)**, **Gene Expression Analysis**, and **Mass Spectrometry**—are used in protein expression proteomics studies, either directly or indirectly, to analyze and quantify proteins.
- The integration of these various techniques provides a comprehensive approach to understanding protein expression profiles.
*PolyAcrylamide Gel Electrophoresis (PAGE)*
- **PAGE** (including 1D and 2D-PAGE) is a fundamental technique for separating proteins based on their **molecular weight** and **isoelectric point**, which is crucial for visualizing and quantifying expressed proteins.
- It often serves as an initial separation step before more detailed analysis, such as **mass spectrometry**.
*Gene Expression Analysis (indirectly related to proteomics)*
- Although **gene expression analysis** (e.g., using **RT-PCR** or **microarrays**) measures mRNA levels, it is indirectly related to proteomics because mRNA levels often **correlate with protein levels**.
- It provides insights into the **transcriptional regulation** that influences protein expression, complementing direct protein analysis.
*Mass Spectrometry*
- **Mass spectrometry** is a powerful and widely used technique in proteomics for **identifying, quantifying, and characterizing proteins** and peptides by measuring their **mass-to-charge ratio**.
- It can be used for both **discovery proteomics** (identifying novel proteins) and **targeted proteomics** (quantifying specific proteins).
Future Directions in Molecular Imaging Indian Medical PG Question 2: Best imaging modality for acoustic neuroma screening
- A. Nuclear scan
- B. CT temporal bone
- C. MRI with gadolinium (Correct Answer)
- D. Plain skull X-ray
Future Directions in Molecular Imaging Explanation: ***MRI with gadolinium***
- **Magnetic Resonance Imaging (MRI) with gadolinium contrast** is the gold standard for acoustic neuroma (vestibular schwannoma) detection due to its superior soft tissue resolution.
- It effectively visualizes **small tumors** arising from the vestibular nerve within the internal auditory canal and cerebellopontine angle.
*Nuclear scan*
- **Nuclear scans** are generally used for assessing metabolic activity or specific tissue uptake, such as in oncology for metastasis detection or thyroid conditions.
- They lack the **anatomical detail and resolution** needed to visualize small intracranial tumors like acoustic neuromas.
*CT temporal bone*
- **CT scans of the temporal bone** are excellent for evaluating bony structures, such as fractures or erosion of the internal auditory canal.
- However, they have **limited sensitivity for soft tissue masses** and can miss small acoustic neuromas.
*Plain skull X-ray*
- **Plain skull X-rays** provide very limited information about soft tissues and are not useful for screening or diagnosing acoustic neuromas.
- They mainly visualize **gross bony abnormalities** and cannot detect subtle pathologies within the internal auditory canal or cerebellopontine angle.
Future Directions in Molecular Imaging Indian Medical PG Question 3: Based on the provided image, which of the following is the correct diagnosis?
- A. Uterus didelphys
- B. Bicornuate Uterus
- C. Unicornuate Uterus (Correct Answer)
- D. Septate uterus
Future Directions in Molecular Imaging Explanation: ***Unicornuate Uterus***
- The image distinctly shows **only one fallopian tube and one rudimentary uterine horn** on the right side, indicating a unicornuate uterus.
- This malformation results from the **incomplete development of one Müllerian duct**, leading to a single, banana-shaped uterine cavity.
*Uterus didelphys*
- This condition involves **two completely separate uteri**, each with its own cervix and vagina.
- The image does not show evidence of two distinct uterine bodies or cervices.
*Bicornuate Uterus*
- A bicornuate uterus is characterized by **two uterine horns that fuse caudally**, creating a heart-shaped appearance with a shared cervix.
- The image clearly lacks the characteristic heart shape and shows only one functional horn.
*Septate uterus*
- A septate uterus has a **fibrous or muscular septum** dividing the uterine cavity, while the external uterine contour remains normal.
- The image does not show a septum or a normal external uterine contour with an internal division; instead, it presents with a single underdeveloped horn.
Future Directions in Molecular Imaging Indian Medical PG Question 4: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Future Directions in Molecular Imaging Explanation: ***Cisplatin***
- **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**.
- It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel.
*Methotrexate*
- **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis.
- While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**.
*Cyclophosphamide*
- **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death.
- It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines.
*Dacarbazine*
- **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma.
- It is **not indicated for the treatment of ovarian carcinoma**.
Future Directions in Molecular Imaging Indian Medical PG Question 5: Gold standard investigation for breast carcinoma screening in a patient with silicone breast implants
- A. Mammography
- B. CT scan
- C. USG
- D. MRI (Correct Answer)
Future Directions in Molecular Imaging Explanation: ***MRI***
- **MRI** is considered the **gold standard** for breast cancer screening in patients with silicone breast implants due to its superior ability to visualize breast tissue through the implant and detect subtle lesions.
- It offers **high sensitivity** in detecting both implant rupture and early malignancies, often providing better clarity than mammography in augmented breasts where implants can obscure tissue.
*Mammography*
- While a standard screening tool, **mammography** can be limited in patients with silicone implants because the implants can **obscure adjacent breast tissue**, making detection of small masses challenging.
- Special views (e.g., **Eklund views**) can be used, but sensitivity is still reduced compared to MRI in augmented breasts.
*CT scan*
- **CT scans** are not routinely used for primary breast cancer screening due to their use of **ionizing radiation** and lower sensitivity for detecting early breast lesions compared to MRI.
- CT is more commonly used for **staging** advanced cancers or evaluating complex masses detected by other modalities.
*USG*
- **Ultrasound (USG)** is a valuable complementary tool, especially for evaluating palpable lumps or clarifying findings from mammography, but it is **operator-dependent** and has a lower overall sensitivity for general screening compared to MRI.
- It is particularly useful for differentiating between **cystic and solid masses** and detecting implant ruptures but is not the gold standard for comprehensive screening in augmented breasts.
Future Directions in Molecular Imaging Indian Medical PG Question 6: TRUS in carcinoma prostate is most useful for?
- A. Evaluating nearby structures for involvement
- B. Identifying suspicious areas in the prostate
- C. Estimating the size of the prostate
- D. Assisting in targeted prostate biopsies (Correct Answer)
Future Directions in Molecular Imaging Explanation: ***Assisting in targeted prostate biopsies***
- **TRUS** (Transrectal Ultrasound) provides real-time imaging, which is crucial for **guiding biopsy needles** accurately to suspicious areas within the prostate that may not be palpable.
- This guidance increases the diagnostic yield of biopsies, ensuring samples are taken from potentially cancerous regions.
*Evaluating nearby structures for involvement*
- While TRUS can visualize the immediate surrounding structures like the **seminal vesicles**, its primary role is not for comprehensive staging of tumor extension outside the prostate, which is better achieved with MRI.
- It helps in assessing direct invasion into seminal vesicles but has limitations for wider regional lymph node or distant metastasis evaluation.
*Identifying suspicious areas in the prostate*
- TRUS can identify **hypoechoic lesions** within the prostate, which are often associated with cancer, but these findings are not specific, and many benign conditions can mimic cancer.
- The main utility is not solely in identifying these areas, but in using this identification to guide subsequent biopsies for definitive diagnosis.
*Estimating the size of the prostate*
- TRUS is highly effective for accurately measuring prostate volume, which is important for estimating PSA density and for surgical planning in benign prostatic hyperplasia (BPH).
- However, while it can measure size, this is not its most diagnostically critical role in the context of carcinoma prostate when considering its unique capabilities.
Future Directions in Molecular Imaging Indian Medical PG Question 7: What is the full form of DICOM?
- A. Direct imaging and colors in medicine
- B. Digital information and connectivity in medicine
- C. Digital imaging and communications in medicine (Correct Answer)
- D. Dependent interconnectivity in medicine
Future Directions in Molecular Imaging Explanation: **Digital imaging and communications in medicine**
- **DICOM** is the international standard for managing and transmitting medical images and related data, ensuring **interoperability** between different medical imaging equipment and systems.
- Its purpose is to facilitate the storage, retrieval, management, and exchange of **medical images**, such as X-rays, CT scans, and MRIs, regardless of the vendor.
*Direct imaging and colors in medicine*
- This option incorrectly describes the purpose and scope of DICOM, which is broader than just "direct imaging" and "colors."
- The standard focuses on the **digital nature** of medical images and the **communication** between devices.
*Digital information and connectivity in medicine*
- While DICOM deals with "digital information" and "connectivity," this option omits the crucial aspect of "imaging" in its description.
- The primary focus of DICOM is on **medical images** and their communication.
*Dependent interconnectivity in medicine*
- This phrase does not accurately represent the function or the components of the **DICOM standard**.
- DICOM enables **independent connectivity** and interoperability rather than dependent interconnectivity.
Future Directions in Molecular Imaging Indian Medical PG Question 8: Radiation-induced necrosis can be diagnosed by:
- A. MRI
- B. CT
- C. PET
- D. Biopsy (Correct Answer)
Future Directions in Molecular Imaging Explanation: ***Biopsy***
- A **biopsy** is the definitive diagnostic method for radiation-induced necrosis, allowing for histological examination of tissue to confirm necrosis and rule out residual or recurrent tumor. [1], [2]
- It provides a direct view of cellular changes, identifying **necrosis, atypical cells**, and ruling out **malignancy**.
*MRI*
- While **MRI** can show structural changes indicative of necrosis (e.g., mass effect, edema), it often cannot definitively differentiate between **radiation necrosis** and **tumor recurrence.** [2]
- It often shows **T1 hypointensity** and **T2 hyperintensity**, but these findings are not specific.
*CT*
- **CT scans** are useful for detecting gross changes like **mass effect** and **edema** but have limited sensitivity for distinguishing necrosis from tumor recurrence.
- It may show **low-density lesions** but lacks the resolution and specificity for precise diagnosis.
*PET*
- **PET scans** measure metabolic activity and can help distinguish between **tumor recurrence** (high uptake) and **radiation necrosis** (low uptake) in some cases.
- However, false positives can occur, as some inflammatory processes in necrosis can also show increased uptake, making it **less definitive** than a biopsy.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1307-1308.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 340-341.
Future Directions in Molecular Imaging Indian Medical PG Question 9: Isotope used in bone scans:
- A. Technetium (Correct Answer)
- B. Chromium
- C. Selenium
- D. Gallium
Future Directions in Molecular Imaging Explanation: **Technetium**
- **Technetium-99m (Tc-99m)** is the most widely used isotope in bone scans due to its ideal physical characteristics, including a short half-life and suitable gamma energy for imaging.
- It rapidly localizes to areas of **increased osteoblastic activity** and blood flow, making it effective for detecting bone pathologies like fractures, infections, and tumors.
*Chromium*
- **Chromium-51** is primarily used for **red blood cell labeling** to assess red cell mass, survival, and gastrointestinal bleeding.
- It is not used for bone imaging because it does not accumulate in bone tissue and has different decay characteristics.
*Selenium*
- **Selenium-75** is used for imaging the **parathyroid glands** (e.g., in hyperparathyroidism) and in some studies of pancreatic function.
- It does not have an affinity for bone tissue and is therefore unsuitable for bone scanning.
*Gallium*
- **Gallium-67** is primarily used in **inflammation and infection imaging** (Ga-67 scans) and some tumor imaging.
- While it can accumulate in some bone pathologies (like osteomyelitis), it is not the primary or preferred isotope specifically for routine bone structural scans.
Future Directions in Molecular Imaging Indian Medical PG Question 10: Parameningeal Rhabdomyosarcoma is best diagnosed by:
- A. MRI (Correct Answer)
- B. CT Scan
- C. SPECT
- D. PET
Future Directions in Molecular Imaging Explanation: ***MRI***
- **Magnetic Resonance Imaging (MRI)** provides excellent soft tissue contrast, which is crucial for visualizing the extent of **parameningeal rhabdomyosarcoma** and its relationship to critical structures like the **meninges**, **brainstem**, and **cranial nerves**.
- It is superior for detecting **intracranial extension**, **bone erosion**, and assessing response to treatment, making it the preferred imaging modality for diagnosis and staging.
*CT Scan*
- **Computed Tomography (CT) scans** are good for evaluating bone involvement and calcifications but offer less detailed soft tissue resolution compared to MRI.
- While it can identify large masses, it may miss subtle extensions or involvement of the **meninges** that are readily seen on MRI.
*SPECT*
- **Single-Photon Emission Computed Tomography (SPECT)** is a nuclear medicine imaging technique primarily used to assess organ function and blood flow, often in cardiology or neurology for functional studies.
- It provides limited anatomical detail for the precise localization and characterization of soft tissue tumors like **rhabdomyosarcoma**.
*PET*
- **Positron Emission Tomography (PET) scans** are excellent for detecting metabolically active tumors, assessing disease burden, and identifying distant metastases, especially when combined with CT (**PET/CT**).
- However, while useful for staging and follow-up, it does not provide the high-resolution anatomical detail of the primary tumor's local extent and its relationship to adjacent structures as effectively as **MRI**.
More Future Directions in Molecular Imaging Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
